Predicting microRNA-disease associations using bipartite local models and hubness-aware regression

References

• Ambros VR. microRNAs: tiny regulators with great potential. Cell. 2001;107(7):823–826.
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281–297.
   PubMed Web of Science ®Google Scholar
• Ambros VR. The functions of animal microRNAs. Nature. 2004;431(7006):350–355.
   PubMed Web of Science ®Google Scholar
• Meister G, Tuschl T. Mechanisms of gene silencing by double-stranded RNA. Nature. 2004;431(7006):343–349.
   PubMed Web of Science ®Google Scholar
• Cheng AM, Byrom M, Shelton J, et al. Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res. 2005;33(4):1290–1297.
   PubMed Web of Science ®Google Scholar
• Karp X, Ambros VR. Encountering MicroRNAs in cell fate signaling. Science. 2005;310(5752):1288–1289.
   PubMed Web of Science ®Google Scholar
• Miska EA. How microRNAs control cell division, differentiation and death. Curr Opin Genet Dev. 2005;15(5):563–568.
   PubMed Web of Science ®Google Scholar
• Xu P, Guo M, Hay BA. MicroRNAs and the regulation of cell death. Trends Genet. 2004;20(12):617–624.
   PubMed Web of Science ®Google Scholar
• Alshalalfa M, Alhajj R. Using context-specific effect of miRNAs to identify functional associations between miRNAs and gene signatures. BMC Bioinformatics. 2013;14(12):1–13.
   PubMedGoogle Scholar
• Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136(2):215–233.
   PubMed Web of Science ®Google Scholar
• Cui Q, Yu Z, Purisima EO, et al. Principles of microRNA regulation of a human cellular signaling network. Mol Syst Biol. 2006;2(1):46.
   PubMedGoogle Scholar
• Lee RC, Feinbaum RL, Ambros VR, et al. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993;75(5):843–854.
   PubMed Web of Science ®Google Scholar
• Wightman B, Ha I, Ruvkun G. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell. 1993;75(5):855–862.
   PubMed Web of Science ®Google Scholar
• Griffithsjones S, Grocock RJ, Van Dongen S, et al. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res. 2006;34(90001):140–144.
   PubMedGoogle Scholar
• Kozomara A, Griffithsjones S. miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res. 2011;39(1):D152–157.
   PubMedGoogle Scholar
• Griffithsjones S, Saini HK, Van Dongen S, et al. miRBase: tools for microRNA genomics. Nucleic Acids Res. 2007;36(1):D154–158.
   Google Scholar
• Latronico MVG, Catalucci D, Condorelli G. Emerging role of MicroRNAs in cardiovascular biology. Circ Res. 2007;101(12):1225–1236.
   PubMed Web of Science ®Google Scholar
• Esquelakerscher A, Slack FJ. Oncomirs–microRNAs with a role in cancer. Nat Rev Cancer. 2006;6(4):259–269.
   PubMed Web of Science ®Google Scholar
• Lu M, Zhang Q, Deng M, et al. An analysis of human MicroRNA and disease associations. PLoS One. 2008;3(10):e3420.
   Web of Science ®Google Scholar
• Yu Z, Li Z, Jolicoeur N, et al. Aberrant allele frequencies of the SNPs located in microRNA target sites are potentially associated with human cancers. Nucleic Acids Res. 2007;35(13):4535–4541.
   PubMed Web of Science ®Google Scholar
• Chandramouli A, Onyeagucha BC, Mercadopimentel ME, et al. MicroRNA-101 (miR-101) post-transcriptionally regulates the expression of EP4 receptor in colon cancers. Cancer Biol Ther. 2012;13(3):175–183.
   PubMed Web of Science ®Google Scholar
• Otsubo T, Akiyama Y, Hashimoto Y, et al. MicroRNA-126 inhibits SOX2 expression and contributes to gastric carcinogenesis. PLoS One. 2011;6(1):e16617.
   PubMed Web of Science ®Google Scholar
• Nathans RS, Chu C, Serquina AK, et al. Cellular microRNA and P bodies modulate host-HIV-1 interactions. Mol Cell. 2009;34(6):696–709.
   PubMed Web of Science ®Google Scholar
• Jiang Q, Hao Y, Wang G, et al. Prioritization of disease microRNAs through a human phenome-microRNAome network. BMC Syst Biol. 2010;4(1):1–9.
   PubMedGoogle Scholar
• Jiang Q, Wang G, Jin S, et al. Predicting human microRNA-disease associations based on support vector machine. Int J Data Min Bioinform. 2013;8(3):282–293.
   PubMed Web of Science ®Google Scholar
• Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer. 2006;6(11):857–866.
   PubMed Web of Science ®Google Scholar
• Chen X. Predicting lncRNA-disease associations and constructing lncRNA functional similarity network based on the information of miRNA. Sci Rep. 2015;5(1):13186.
   PubMedGoogle Scholar
• Chen X. KATZLDA: KATZ measure for the lncRNA-disease association prediction. Sci Rep. 2015;5(1):16840.
   PubMedGoogle Scholar
• Chen X, Liu M, Cui Q, et al. Prediction of disease-related interactions between microRNAs and environmental factors based on a semi-supervised classifier. PLoS One. 2012;7(8):e43425.
   PubMed Web of Science ®Google Scholar
• Chen X, Liu M, Yan G. RWRMDA: predicting novel human microRNA–disease associations. Mol Biosyst. 2012;8(10):2792–2798.
   PubMed Web of Science ®Google Scholar
• Chen X, Yan CC, Luo C, et al. Constructing lncRNA functional similarity network based on lncRNA-disease associations and disease semantic similarity. Sci Rep. 2015;5(1):11338.
   PubMedGoogle Scholar
• Chen X, Yan CC, Zhang X, et al. RBMMMDA: predicting multiple types of disease-microRNA associations. Sci Rep. 2015;5(1):13877.
   PubMedGoogle Scholar
• Chen X, Yan G. Novel human lncRNA-disease association inference based on lncRNA expression profiles. Bioinformatics. 2013;29(20):2617–2624.
   PubMed Web of Science ®Google Scholar
• Chen X, Yan G. Semi-supervised learning for potential human microRNA-disease associations inference. Sci Rep. 2015;4(1):5501.
   Google Scholar
• Chen X, Xie D, Zhao Q, et al. MicroRNAs and complex diseases: from experimental results to computational models. Brief Bioinform. 2017;bbx130–bbx.
   Web of Science ®Google Scholar
• Pereziratxeta C, Wjst M, Bork P, et al. G2D: a tool for mining genes associated with disease. BMC Genet. 2005;6(1):45.
   PubMedGoogle Scholar
• Aerts S, Lambrechts D, Maity S, et al. Gene prioritization through genomic data fusion. Nat Biotechnol. 2006;24(5):537–544.
   PubMed Web of Science ®Google Scholar
• Pereziratxeta C, Bork P, Andrade MA. Association of genes to genetically inherited diseases using data mining. Nat Genet. 2002;31(3):316–319.
   PubMed Web of Science ®Google Scholar
• Xuan P, Han K, Guo M, et al. Prediction of microRNAs associated with human diseases based on weighted k most similar neighbors. PLoS One. 2013;8(8):e70204.
   PubMed Web of Science ®Google Scholar
• Mork S, Pletscherfrankild S, Caro AP, et al. Protein-driven inference of miRNA-disease associations. Bioinformatics. 2014;30(3):392–397.
   PubMed Web of Science ®Google Scholar
• Xuan P, Han K, Guo Y, et al. Prediction of potential disease-associated microRNAs based on random walk. Bioinformatics. 2015;31(11):1805–1815.
   PubMed Web of Science ®Google Scholar
• Chen X, Yan CC, Zhang X, et al. WBSMDA: within and between score for MiRNA-disease association prediction. Sci Rep. 2016;6(1):21106.
   PubMedGoogle Scholar
• Chen X, Yan CC, Zhang X, et al. HGIMDA: heterogeneous graph inference for miRNA-disease association prediction. Oncotarget. 2016;7(40):65257–65269.
   PubMedGoogle Scholar
• Li JQ, Rong ZH, Chen X, et al. MCMDA: matrix completion for MiRNA-disease association prediction. Oncotarget. 2017;8(13):21187–21199.
   PubMedGoogle Scholar
• Pasquier C, Gardes J. Prediction of miRNA-disease associations with a vector space model. Sci Rep. 2016;6(1):27036.
   PubMedGoogle Scholar
• Yu H, Chen X, Lu L. Large-scale prediction of microRNA-disease associations by combinatorial prioritization algorithm. Sci Rep. 2017;7:43792.
   PubMed Web of Science ®Google Scholar
• Chen X, Wu Q-F, Yan G-Y. RKNNMDA: ranking-based KNN for MiRNA-disease association prediction. RNA Biol. 2017;14(7):952–962.
   PubMed Web of Science ®Google Scholar
• Radovanovic M, Nanopoulos A, Ivanovic M. Hubs in space: popular nearest neighbors in high-dimensional data. J Machine Learn Res. 2010;11:2487–2531.
   Web of Science ®Google Scholar
• Jiang Q, Wang Y, Hao Y, et al. miR2Disease: a manually curated database for microRNA deregulation in human disease. Nucleic Acids Res. 2009;37:D98–104.
   Web of Science ®Google Scholar
• Dawsey SP, Tonui S, Parker RK, et al. Esophageal cancer in young people: a case series of 109 cases and review of the literature. PLoS One. 2010;5(11):e14080.
   Web of Science ®Google Scholar
• Bosetti C, Levi F, Ferlay J, et al. Trends in oesophageal cancer incidence and mortality in Europe. Int J Cancer. 2007;122(5):1118–1129.
   Web of Science ®Google Scholar
• Hiyoshi Y, Kamohara H, Karashima R, et al. MicroRNA-21 regulates the proliferation and invasion in esophageal squamous cell carcinoma. Clin Cancer Res. 2009;15(6):1915–1922.
   PubMed Web of Science ®Google Scholar
• Xu X, Jiang Y, Feng J, et al. MicroRNA-17, MicroRNA-18a, and MicroRNA-19a are prognostic indicators in esophageal squamous cell carcinoma. Ann Thorac Surg. 2014;97(3):1037–1045.
   PubMed Web of Science ®Google Scholar
• Liu R, Liao J, Yang M, et al. Circulating miR-155 expression in plasma: a potential biomarker for early diagnosis of esophageal cancer in humans. J Toxicol Environ Health. 2012;75(18):1154–1162.
   PubMed Web of Science ®Google Scholar
• Wang G, Tam L-S, Li E, et al. Serum and urinary cell free MiR-146a and MiR-155 in patients with systemic lupus erythematosus. J Rheumatol. 2010;37(12):2516–2522.
   PubMedGoogle Scholar
• Xue Z, Wen J, Chu X, et al. A microRNA gene signature for identification of lung cancer. Surg Oncol. 2014;23(3):126–131.
   PubMed Web of Science ®Google Scholar
• Jemal A, Siegel RL, Xu J, et al. Cancer statistics, 2010. CA Cancer J Clin. 2010;60(5):277–300.
   PubMed Web of Science ®Google Scholar
• Brambilla E, Travis WD, Colby TV, et al. The new World Health Organization classification of lung tumours. Eur Respir J. 2001;18(6):1059–1068.
   PubMed Web of Science ®Google Scholar
• Wang J, Zhao YC, Lu YD, et al. Integrated bioinformatics analyses identify dysregulated miRNAs in lung cancer. Eur Rev Med Pharmacol Sci. 2014;18(16):2270.
   PubMed Web of Science ®Google Scholar
• She J, Yang P, Hong Q, et al. Lung cancer in China: challenges and interventions. Chest. 2013;143(4):1117–1126.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63(1):11–30.
   PubMed Web of Science ®Google Scholar
• Scott WJ, Howington J, Feigenberg S, et al. Treatment of Non-Small Cell Lung Cancer Stage I and stage II: ACCP evidence-based clinical practice guidelines (2nd Edition). Chest. 2007;132(3):234S-242S.
   PubMed Web of Science ®Google Scholar
• Van Zandwijk N. Neoadjuvant strategies for non-small cell lung cancer. Lung Cancer. 2001;34:S145-S150.
   PubMedGoogle Scholar
• Markou A, Tsaroucha EG, Kaklamanis L, et al. Prognostic value of mature MicroRNA-21 and MicroRNA-205 overexpression in non–small cell lung cancer by quantitative real-time RT-PCR. Clin Chem. 2008;54(10):1696–1704.
   PubMed Web of Science ®Google Scholar
• Yanaihara N, Caplen NJ, Bowman ED, et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell. 2006;9(3):189–198.
   PubMed Web of Science ®Google Scholar
• Ebi H, Sato T, Sugito N, et al. Counterbalance between RB inactivation and miR-17-92 overexpression in reactive oxygen species and DNA damage induction in lung cancers. Oncogene. 2009;28(38):3371–3379.
   PubMed Web of Science ®Google Scholar
• Sato F, Hatano E, Kitamura K, et al. MicroRNA profile predicts recurrence after resection in patients with hepatocellular carcinoma within the Milan Criteria. PLoS One. 2011;6(1):e16435.
   Web of Science ®Google Scholar
• Taylorrobinson SD, Foster GR, Arora S, et al. Increase in primary liver cancer in the UK, 1979–94. Lancet. 1997;350(9085):1142–1143.
   Web of Science ®Google Scholar
• Elserag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med. 1999;340(10):745–750.
   PubMed Web of Science ®Google Scholar
• Connolly E, Melegari M, Landgraf P, et al. Elevated expression of the miR-17-92 polycistron and miR-21 in hepadnavirus-associated hepatocellular carcinoma contributes to the malignant phenotype. Am J Pathol. 2008;173(3):856–864.
   PubMed Web of Science ®Google Scholar
• Li Y, Qiu C, Tu J, et al. HMDD v2.0: a database for experimentally supported human microRNA and disease associations. Nucleic Acids Res. 2014;42:D1070–1074.
   Web of Science ®Google Scholar
• Wang D, Wang J, Lu M, et al. Inferring the human microRNA functional similarity and functional network based on microRNA-associated diseases. Bioinformatics. 2010;26(13):1644–1650.
   PubMed Web of Science ®Google Scholar
• Lipscomb CE. Medical subject headings (MeSH). Bull Med Libr Assoc. 2000;88(3):265–266.
   PubMedGoogle Scholar
• Chen X, Wang L, Qu J, et al. Predicting miRNA-disease association based on inductive matrix completion. Bioinformatics. 2018;bty503–bty.
   Google Scholar
• Chen X, Xie D, Wang L, et al. BNPMDA: bipartite network projection for MiRNA–disease association prediction. Bioinformatics. 2018;bty333–bty.
   Google Scholar
• Chen X, Huang L. LRSSLMDA: laplacian regularized sparse subspace learning for MiRNA-disease association prediction. PLoS Comput Biol. 2017;13(12):e1005912.
   PubMed Web of Science ®Google Scholar
• You Z, Huang Z, Zhu Z, et al. PBMDA: A novel and effective path-based computational model for miRNA-disease association prediction. PLoS Comput Biol. 2017;13(3):e1005455.
   PubMed Web of Science ®Google Scholar
• Van Laarhoven T, Nabuurs SB, Marchiori E. Gaussian interaction profile kernels for predicting drug–target interaction. Bioinformatics. 2011;27(21):3036–3043.
   PubMed Web of Science ®Google Scholar
• Pilaszy I, Tikk D, editors. Recommending new movies: even a few ratings are more valuable than metadata. conference on recommender systems; 2009.
   Google Scholar
• Bleakley K, Yamanishi Y. Supervised prediction of drug-target interactions using bipartite local models. Bioinformatics. 2009;25(18):2397–2403.
   PubMed Web of Science ®Google Scholar
• Buza K, Nanopoulos A, Nagy G. Nearest neighbor regression in the presence of bad hubs. Knowl Based Syst. 2015;86:250–260.
   Web of Science ®Google Scholar